Case Study:

m61

In 2008, Marla and Barry Beck were inspired to create a clean clinical skincare line with the efficacy of dermatologist grade ingredients without all the nasty petrochemicals typically found in the formulations. The first of its kind in the industry, the line was born from the needs and wants of the Bluemercury customer.

The challenges were real – raw material suppliers and manufacturers resisted, claimed insurmountable hurdle, or simply said it “couldn’t be done.” Undaunted, our team worked on everything from formulation to manufacturing to bring this idea to market.

That groundbreaking idea became the best-selling m61 line, now the best-selling skincare within the bluemercury ecosystem.

We ensured the m61 line was industry-leading and clinically proven, resulting in a highly profitable brand top-ranked in its category.

Success for the line resulted in an acquisition for $210 million by Macy’s in 2015